drjamesbluett

Rheumatologist, University of Manchester. Interests in personalised medicine, inflammatory arthritis. Views my own

[NIHR Biomedical Research Centre: Manchester @ManchesterBRC]

How could AI be used to help tailor treatments for juvenile idiopathic arthritis (JIA)? 💡

Read about pioneering research which is kick-starting the movement of stratified medicine for JIA, with insights from Dr Stephanie Shoop-Worrall 👇

🔗https://t.co/cPxsfyMEGO

[NIHR Biomedical Research Centre: Manchester @ManchesterBRC]

For 13-year-old Trinity, being on the drug methotrexate for her polyarticular-JIA was a ‘double-edged sword’.

Read Trinity’s story, as told by her mum Rebecca, and why targeted medicines are important 👇
https://t.co/cPxsfyMEGO

[drjamesbluett @drjamesbluett]

@VersusArthritis 3

[Liverpool University Jobs @livunijobs]

🚨- @LivUniISMIB is recruiting - 👀see https://t.co/i5miHuIcMu for full details and how to apply @LivUniHLS @livunijobs

[Association of Physicians, GB & Ireland @AoPgbi]

Dr. James Bluett (MBBS, MRes, MSc, PhD) is a Senior Clinical Lecturer and Honorary Consultant in Rheumatology at the University of Manchester. 🎓

He earned his PhD in 2016, focusing on methotrexate adherence in rheumatoid arthritis and the genetic factors behind methotrexate-induced pneumonitis. His research spans pharmacogenomics, treatment optimization, and medication adherence.

A previous AoPGBI Award Winner, Bluett is dedicated to supporting future scientists and clinicians; supervising PhD, MSc, and medical students, leading a number of academic positions, and educates online and at events.

Join him LIVE at a FREE webinar on 20th September at 12:00-13:00 BST on https://t.co/gXgueY0m1n

#RheumatologyWebinar #MedicalEducation #ClinicianTraining #RheumatologyUpdate #HealthcareProfessionals #ContinuingMedicalEducation #RheumatologyExperts #MedicalWebinar #ProfessionalDevelopment #RheumatologyCare #Dermatologists #Pharmacists #Rheumatologists #DermatologyAlliedHealthProfessionals

[NIHR Biomedical Research Centre: Manchester @ManchesterBRC]

Thinking of applying for an #academic clinical #fellowship in rheumatology? Want to learn more about life as an academic doctor?

Register for the Rheumatology Academic Clinical Fellowship Webinar on October 14 👇
https://t.co/e4L2qBXvx2

@FBMH_UoM @OfficialUoM @drjamesbluett

[NIHR Biomedical Research Centre: Manchester @ManchesterBRC]

Manchester BRC Director Prof Anne Barton & RMD Co-Theme Lead @drjamesbluett presenting at GM Inflammation Research Showcase today - on how we can help drive research collaboration 👏

#GMInflamShowcase

[UoM Musculoskeletal @UoMMskResearch]

New research from the OUTPASS #psoriatic arthritis study reveals that deprivation does not significantly impact access to or response to biologic treatments in the UK. Learn more in Rheumatology Advances in Practice🔽 #rheumatology #psoriaticarthritis

https://t.co/ormVleRyAg

[Hippocrates-IMI @Hippocrates_IMI]

Prof. McInnes entertained us with a great deal of expertise and humour. Thanks for inviting such an outstanding speaker. Looking forward to more inspiration and football metaphors at our working dinner.

[Liverpool University Jobs @livunijobs]

💥Great opportunity @LivUniISMIB @LivUniHLS
The MRC #Medicines Development #Fellowship Scheme offers a unique opportunity for four #Clinician #Scientist Fellows to develop into independent cross-boundary #research leaders.
Further information here➡️https://t.co/ud2tMyXTJW

[MFT Research and Innovation @MFT_Research]

Dr Jonathan Bannard-Smith, Critical Care Consultant at @MFT_MRI, is encouraging doctors to take their first step into research through the NIHR Associate Principal Investigator (API) scheme.

Read more 👇
https://t.co/GQcLskVxxJ

[Jim Ritchie @ChorltonJim]

How work at @HealthInnovMcr and the Greater Manchester Care Record is supporting better kindly health for all on #WorldKidneyDay2024

[NIHR Biomedical Research Centre: Manchester @ManchesterBRC]

Manchester BRC researchers have been awarded a £1.8m grant to help identify effective steroid use for people with rheumatoid arthritis.

The LEADER study will assess whether an injection or daily tablet is better at controlling the disease.

Read more 👇
https://t.co/zHGTZd3E92

[NIHR Biomedical Research Centre: Manchester @ManchesterBRC]

A trial supported by Manchester BRC researchers has shown people with inflammatory conditions can improve antibody response from the COVID-19 booster by interrupting their treatment for 2 weeks immediately after having the vaccine.

Read more 👇
https://t.co/brGjJWe2WX

[drjamesbluett @drjamesbluett]

How can you support and measure #methotrexate #adherence come and join me at #acr23 poster 2111 to see the results of the MIRA trial

[drjamesbluett @drjamesbluett]

https://t.co/V2KISXASm9

[drjamesbluett @drjamesbluett]

Fantastic talk from Prof Abhishek at #ACR23 on pausing #methotrexate after the #covid19 booster and antibody response. Read more 👇

[drjamesbluett @drjamesbluett]

Fantastic symposium organised by @RCPEManc very grateful to them in inviting me to talk about the methotrexate adherence blood test
https://t.co/v9lkH2rJl0 #adherence19